Evidence map›Paper›PMID 35023268›Full record

ArticleCancer science2022

18F-fluorodeoxyglucose uptake in PET is associated with the tumor microenvironment in metastatic lymph nodes and prognosis in N2 lung adenocarcinoma.

Kotaro Nomura, Tokiko Nakai, Yukino Nishina, Naoya Sakamoto, Tomohiro Miyoshi, Kenta Tane, Joji Samejima, Keiju Aokage, Motohiro Kojima, Shingo Sakashita and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Kotaro NomuraDepartment of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
Tokiko NakaiDepartment of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
Yukino NishinaDepartment of Integrated Biosciences, Laboratory of Cancer Biology, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan.
Naoya SakamotoDepartment of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.ORCID https://orcid.org/0000-0001-6273-0189
Tomohiro MiyoshiDepartment of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Japan.
Kenta TaneDepartment of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Japan.ORCID https://orcid.org/0000-0002-7737-8277
Joji SamejimaDepartment of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Japan.
Keiju AokageDepartment of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Japan.
Motohiro KojimaDepartment of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.ORCID https://orcid.org/0000-0002-6150-6545
Shingo SakashitaDepartment of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
Tetsuro TakiDepartment of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
Saori MiyazakiDepartment of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
Reiko WatanabeDepartment of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
Kenji SuzukiDepartment of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Masahiro TsuboiDepartment of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Japan.
Genichiro IshiiDepartment of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.ORCID https://orcid.org/0000-0001-8637-3323
National Cancer Center Hospital East · JPJuntendo University · JP

Funding

Japan Society for the Promotion of Science 21H02931National Cancer Center Research and Development Fund 2020-A-9
6 · The paper itself

Abstract

Positron emission tomography is a useful technique for diagnosing lymph node (LN) metastasis. This study aimed to elucidate the association between fluorodeoxyglucose accumulation and the microenvironment in metastatic LNs in lung adenocarcinoma. We retrospectively analyzed 62 patients with surgically resected pathological N2 lung adenocarcinoma who underwent preoperative PET. The maximum standardized uptake value (SUV

Indexed as

Adenocarcinoma of LungLung NeoplasmsFluorodeoxyglucose F18HumansLymphatic MetastasisLymph NodesPositron-Emission TomographyPositron Emission Tomography Computed TomographyPrognosisRetrospective StudiesTumor MicroenvironmentFluorodeoxyglucose F1818F-fluorodeoxyglucose-positron emission tomographycancer-associated fibroblastlung adenocarcinomalymph node metastasisprognosis

Identifiers

PMID35023268
PMCPMC8990723
OpenAlexW4205745490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.